GRAL (STOCKS)
GRAIL, Inc. Common Stock
$48.040000
+2.410000 (+5.28%)
Prev close: $45.630000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Robert P. Ragusa
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,968.97M
- Employees
- 1,000
- P/E (TTM)
- -4.30
- P/B (TTM)
- 0.71
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
4
Strong Buy
5
Buy
3
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-2.44 | $-2.76 | +0.3201 | +11.60% |
|
Sep 2025 (Q3)
|
$-2.46 | $-3.59 | +1.1279 | +31.44% |
|
Jun 2025 (Q2)
|
$-3.18 | $-3.64 | +0.4589 | +12.61% |
|
Mar 2025 (Q1)
|
$-3.09 | $-4.17 | +1.0818 | +25.93% |
Financial Statements
| Revenues | $147.17M |
| Benefits Costs and Expenses | $681.68M |
| Costs And Expenses | $709.34M |
| Nonoperating Income/Loss | $27.66M |
| Operating Expenses | $709.34M |
| Research and Development | $195.79M |
| Other Operating Expenses | $513.54M |
| Operating Income/Loss | -$562.16M |
| Income/Loss From Continuing Operations After Tax | -$408.35M |
| Income/Loss From Continuing Operations Before Tax | -$534.50M |
| Income Tax Expense/Benefit | -$126.15M |
| Income Tax Expense/Benefit, Current | $1.13M |
| Income Tax Expense/Benefit, Deferred | -$126.15M |
| Net Income/Loss | -$408.35M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$408.35M |
| Net Income/Loss Available To Common Stockholders, Basic | -$408.35M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Provision For Loan, Lease, And Other Losses | $332.00K |
| Basic Earnings Per Share | -$11.11 |
| Diluted Earnings Per Share | -$11.11 |
| Basic Average Shares | 36,753,751 |
| Diluted Average Shares | 36,753,751 |
| Assets | $2.92B |
| Current Assets | $953.85M |
| Cash | $901.94M |
| Other Current Assets | $51.91M |
| Noncurrent Assets | $1.97B |
| Fixed Assets | $51.81M |
| Intangible Assets | $1.85B |
| Other Non-current Assets | $65.80M |
| Liabilities | $344.15M |
| Current Liabilities | $79.67M |
| Accounts Payable | $2.08M |
| Wages | $36.30M |
| Other Current Liabilities | $41.29M |
| Noncurrent Liabilities | $264.48M |
| Equity | $2.58B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $2.58B |
| Liabilities And Equity | $2.92B |
| Net Cash Flow From Operating Activities | -$299.01M |
| Net Cash Flow From Operating Activities, Continuing | -$299.01M |
| Net Cash Flow From Investing Activities | -$85.05M |
| Net Cash Flow From Investing Activities, Continuing | -$85.05M |
| Net Cash Flow From Financing Activities | $423.32M |
| Net Cash Flow From Financing Activities, Continuing | $423.32M |
| Exchange Gains/Losses | -$147.00K |
| Net Cash Flow | $39.12M |
| Net Cash Flow, Continuing | $39.27M |
| Comprehensive Income/Loss | -$407.15M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$407.15M |
| Other Comprehensive Income/Loss | -$407.15M |
| Other Comprehensive Income/Loss Attributable To Parent | $1.20M |